Duplat Depot 11.25, Leuprolide Acetate, AntiCancer Drugs, Online Pharmacy, ZarvyPharm
AntiCancer Drugs Uterine Fibroid Prostate Cancer

Duplat Depot 11.25, Injection

★★★★★
★★★★★
0

(0)

Generic For LUPRON
Active Ingredient LEUPROLIDE ACETATE
Strength 11.25MG
Manufacturer SAMARTH LIFE SCIENCES PVT LTD
Duplat Depot 11.25 (Leuprolide Acetate) injection 11.25mg carton box with branded label for online pharmacy prostate cancer treatment
Duplat Depot 11.25 (Leuprolide Acetate) injection 11.25mg pre-filled syringe packaging with accessories for hormone therapy online pharmacy
Duplat Depot 11.25 (Leuprolide Acetate) injection 11.25mg carton box angled display with kit contents for oncology supportive care online pharmacy
Duplat Depot 11.25 (Leuprolide Acetate) injection 11.25mg carton box with branded label for online pharmacy prostate cancer treatment
Duplat Depot 11.25 (Leuprolide Acetate) injection 11.25mg pre-filled syringe packaging with accessories for hormone therapy online pharmacy
Duplat Depot 11.25 (Leuprolide Acetate) injection 11.25mg carton box angled display with kit contents for oncology supportive care online pharmacy
Best available coupon applied for preview!
Use code ZARVY26 at checkout to get 15% OFF your order.
COUPON CODE
ZARVY26
15% OFF
Pack Size Price Per Unit Unit Price QTY CART Best Coupon Price
MAX DISCOUNT
1 BOX - 1 VIAL $ 105.50 $ 105.50
$ 89.68
Apply ZARVY26 (-15%)
You save $ 15.83
2 BOXES - 2 VIALS $ 106.10 $ 212.20
$ 180.37
Apply ZARVY26 (-15%)
You save $ 31.83
★ Best Value 3 BOXES - 3 VIALS $ 109.40 $ 328.20
$ 278.97
Apply ZARVY26 (-15%)
You save $ 49.23

Exchange & Returns Information

 

 

Reference

Reference information will be available soon.

Product Description

Duplat Depot 11.25 is a 3-month depot injection containing leuprolide acetate 11.25mg, a gonadotropin-releasing hormone (GnRH) agonist used in multiple hormone-responsive conditions. By providing continuous GnRH receptor stimulation, it induces downregulation of the pituitary–gonadal axis, leading to suppression of testosterone and estrogen production.

This mechanism results in a reversible chemical castration effect, making it an important therapy in the management of:

  • Advanced prostate cancer

  • Endometriosis

  • Uterine fibroids

  • Central precocious puberty

The 11.25mg long-acting formulation enables quarterly dosing, offering both treatment convenience and consistent hormonal suppression for long-term disease control.

Indications & Uses

  • AntiCancer Drugs > Prostate Cancer
    Indicated for palliative treatment of advanced, recurrent, or metastatic prostate cancer. It lowers circulating testosterone levels to castrate range, thereby slowing tumor progression and alleviating associated symptoms. The 11.25mg depot formulation ensures reliable hormonal suppression for a 3-month duration.

  • Hormones & Menopausal Symptoms > Endometriosis
    Used to induce a temporary menopausal state and reduce ectopic endometrial tissue activity. Treatment typically lasts up to 6 months, with injections administered every 3 months to relieve pelvic pain, dysmenorrhea, and menstrual irregularities.

  • Hormones & Menopausal Symptoms > Uterine Fibroid
    Employed as a preoperative intervention to reduce fibroid volume and control abnormal bleeding. By suppressing estrogen-dependent fibroid growth, it can also improve hemoglobin levels prior to surgery.

  • Hormones & Menopausal Symptoms > Precocious Puberty
    Indicated for children with central precocious puberty to delay early sexual maturation. Weight-adjusted regimens are used to achieve adequate hormone suppression, while the 3-month depot formulation allows for long-term maintenance with fewer injections.

Benefits & Effectiveness

Leuprolide acetate works through continuous stimulation of pituitary GnRH receptors, which initially causes a surge in LH and FSH, but is followed by receptor desensitization and subsequent hormonal suppression.

  • In men, this leads to a marked reduction in testosterone production, effectively mimicking the effects of orchiectomy.

  • In women and children, it lowers estrogen levels, thereby suppressing premature or pathological hormonal activity.

The depot injection provides a sustained release, ensuring consistent efficacy and reducing the frequency of dosing. While it is not curative, it plays a central role in the long-term control of hormone-dependent diseases.

Directions for Use

  • Prostate Cancer (Adults):
    → 7.5 mg IM every 4 weeks
    → 22.5 mg IM every 12 weeks
    → 30 mg IM every 16 weeks
    → 45 mg IM every 24 weeks
    → Duplat Depot 11.25: administered every 3 months
    → Subcutaneous alternatives: CAMCEVI 42 mg (q6mo), ELIGARD (7.5–45 mg)

  • Endometriosis (Adults):
    → 3.75 mg IM monthly or
    → 11.25 mg IM every 3 months (max duration: 12 months)
    → Often co-prescribed with norethindrone to mitigate bone loss

  • Uterine Fibroid (Adults):
    → 3.75 mg IM monthly (for up to 3 months) or
    → 11.25 mg IM once as preoperative management

  • Central Precocious Puberty (Children ≥1 year):
    → ≤25 kg: 7.5 mg IM monthly
    → 25–37.5 kg: 11.25 mg monthly
    → >37.5 kg: 15 mg IM monthly
    → 11.25 or 30 mg every 3 months
    → Subcutaneous: FENSOLVI 45 mg every 6 months (≥2 years)

  • Administration Notes:
    → Must be administered by a healthcare professional via deep intramuscular injection
    → Avoid missing scheduled dosing intervals
    → If a dose is missed, take it as soon as possible and continue the regular schedule. Do not double the next dose
    → Monitor hormone levels and disease progression regularly during long-term therapy

Storage

  • Store in the original packaging under refrigeration or at controlled room temperature (below 25°C), according to formulation instructions

  • Do not freeze

  • Protect from light and excessive moisture

  • Keep out of reach of children

  • Do not use if the solution appears discolored or contains particles

Possible Side Effects

  • Common: injection site pain, hot flashes, decreased libido, fatigue, emotional lability

  • Less common: gynecomastia, edema, acne, bone density loss, headache

  • Rare: cardiovascular events, depression, pituitary apoplexy, allergic reactions

  • Patients should stop treatment and consult a physician if they experience chest tightness, severe mood changes, or unusual bleeding.

FAQs

It is used to treat advanced prostate cancer, endometriosis, uterine fibroids, and precocious puberty by suppressing sex hormone production.
It desensitizes GnRH receptors in the pituitary gland, leading to reduced secretion of sex hormones like testosterone and estrogen.
No. The effects are reversible upon discontinuation, making it a temporary form of chemical castration.
It is injected once every 3 months by a healthcare professional.
Yes. It is approved for use in central precocious puberty and is dosed based on weight and developmental stage.

Ratings & Reviews

Reviewed by 0 Users

0/5
★★★★★
★★★★★
5★
0%
4★
0%
3★
0%
2★
0%
1★
0%

Write a Review:

✓ The 'Write a Review' button appears only when an order includes this product and the product item in that order is marked as 'Delivered'.

✓ Clicking the button will redirect you to 'My Account > Orders > Orders Processing', where you can leave a review for a delivered item.

💡 Each product item can be reviewed only once, after it has been marked as 'Delivered'.


Multiple orders:

✓ If you bought this product more than once on different days, you can write a separate review for each order.

💡 When Order A is marked 'Delivered', the button takes you to Order A's details page.

Later, when Order B is also marked Delivered, the button stays active and takes you to Order B's details page for another review.

No reviews yet. Be the first to review this product!

Alternatives

Combo Deals

No combo deals available at the moment.